• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于壳聚糖衍生物修饰介孔二氧化硅纳米粒子的用于药物和基因共递送的氧化还原响应性纳米载体

Redox-responsive nanocarriers for drug and gene co-delivery based on chitosan derivatives modified mesoporous silica nanoparticles.

作者信息

Lin Jian-Tao, Liu Zong-Kun, Zhu Qing-Ling, Rong Xiao-Hui, Liang Cui-Ling, Wang Jie, Ma Dong, Sun Jing, Wang Guan-Hai

机构信息

Guangdong Key Laboratory for Research and Development of Natural Drugs, Guangdong Medical University, Zhanjiang 523024, China; Traditional Chinese Medicine and New Drug Research Institute, Guangdong Medical University, Dongguan, 523808, China.

The Third People's Hospital of Jiaozhou, Qiaodao, 266300, China.

出版信息

Colloids Surf B Biointerfaces. 2017 Jul 1;155:41-50. doi: 10.1016/j.colsurfb.2017.04.002. Epub 2017 Apr 5.

DOI:10.1016/j.colsurfb.2017.04.002
PMID:28407530
Abstract

Stimuli-responsive nanocarriers for anticancer drug and gene co-delivery are promising strategy in cancer therapy. The ultimate goal is to deliver high local concentration of therapeutic agents with no premature release and result in synergistic effects for combination therapies. In this work, we developed a redox stimuli-responsive and synergistic co-delivery system for anticancer drug DOX and p53 gene for potential cancer therapy. A dendronized chitosan derivative (CP) as a "gatekeeper" to control release the drug was used to modify MSNs via a disulfide linker and improve the gene transfection efficiency. Stimulus-induced release of the DOX was studied in the presence of glutathione (GSH), which showed that polymer shell was shed and accelerated the release of embedded drugs inside the tumor cells under a GSH-rich environment. The obtained nanoparticles showed good gene delivery ability in vitro by inducing an obvious increase in p53 protein expression in Hela cells. Apoptosis analysis confirmed that DOX and p53 could be co-delivered to the Hela cells by MSN-SS-CP nanocarriers and induced significant cell apoptosis. These results demonstrated that the dual delivery system resulted in synergistic effects and lead to an effective cancer cell apoptosis, which may be promising for cancer therapeutic application.

摘要

用于抗癌药物和基因共递送的刺激响应性纳米载体是癌症治疗中有前景的策略。最终目标是在不提前释放的情况下递送高局部浓度的治疗剂,并产生联合治疗的协同效应。在这项工作中,我们开发了一种用于抗癌药物阿霉素(DOX)和p53基因的氧化还原刺激响应性协同共递送系统,用于潜在的癌症治疗。一种作为“守门人”来控制药物释放的树枝状壳聚糖衍生物(CP)通过二硫键连接用于修饰介孔二氧化硅纳米颗粒(MSNs),并提高基因转染效率。在谷胱甘肽(GSH)存在的情况下研究了阿霉素的刺激诱导释放,结果表明在富含GSH的环境中,聚合物壳脱落并加速了肿瘤细胞内包封药物的释放。所获得的纳米颗粒通过诱导Hela细胞中p53蛋白表达明显增加,在体外显示出良好的基因递送能力。凋亡分析证实,阿霉素和p53可以通过MSN-SS-CP纳米载体共递送至Hela细胞,并诱导显著的细胞凋亡。这些结果表明,双递送系统产生了协同效应并导致有效的癌细胞凋亡,这可能在癌症治疗应用中具有前景。

相似文献

1
Redox-responsive nanocarriers for drug and gene co-delivery based on chitosan derivatives modified mesoporous silica nanoparticles.基于壳聚糖衍生物修饰介孔二氧化硅纳米粒子的用于药物和基因共递送的氧化还原响应性纳米载体
Colloids Surf B Biointerfaces. 2017 Jul 1;155:41-50. doi: 10.1016/j.colsurfb.2017.04.002. Epub 2017 Apr 5.
2
Fluorescent carbon dot modified mesoporous silica nanocarriers for redox-responsive controlled drug delivery and bioimaging.用于氧化还原响应性控释药物递送和生物成像的荧光碳点修饰介孔二氧化硅纳米载体
J Colloid Interface Sci. 2016 Dec 1;483:343-352. doi: 10.1016/j.jcis.2016.08.033. Epub 2016 Aug 13.
3
Multifunctional mesoporous silica nanoparticles modified with tumor-shedable hyaluronic acid as carriers for doxorubicin.用可被肿瘤脱落的透明质酸修饰的多功能介孔二氧化硅纳米颗粒作为阿霉素的载体
Colloids Surf B Biointerfaces. 2016 Aug 1;144:293-302. doi: 10.1016/j.colsurfb.2016.04.015. Epub 2016 Apr 8.
4
Sterically Stabilised Polymeric Mesoporous Silica Nanoparticles Improve Doxorubicin Efficiency: Tailored Cancer Therapy.立体稳定聚合物介孔硅纳米粒子提高多柔比星的效率:定制癌症治疗。
Molecules. 2020 Feb 8;25(3):742. doi: 10.3390/molecules25030742.
5
Redox-responsive mesoporous silica nanoparticles: a physiologically sensitive codelivery vehicle for siRNA and doxorubicin.氧化还原响应性介孔硅纳米颗粒:siRNA 和阿霉素的生理敏感共递药载体。
Antioxid Redox Signal. 2014 Aug 10;21(5):707-22. doi: 10.1089/ars.2012.5076. Epub 2013 Sep 28.
6
A dual-sensitive mesoporous silica nanoparticle based drug carrier for cancer synergetic therapy.一种基于双敏感介孔硅纳米粒子的药物载体用于癌症协同治疗。
Colloids Surf B Biointerfaces. 2019 Mar 1;175:65-72. doi: 10.1016/j.colsurfb.2018.11.071. Epub 2018 Nov 28.
7
pH-responsive poly (acrylic acid)-gated mesoporous silica and its application in oral colon targeted drug delivery for doxorubicin.pH响应性聚(丙烯酸)门控介孔二氧化硅及其在阿霉素口服结肠靶向给药中的应用。
Colloids Surf B Biointerfaces. 2017 Jun 1;154:287-296. doi: 10.1016/j.colsurfb.2017.03.024. Epub 2017 Mar 14.
8
Redox and pH dual-responsive PEG and chitosan-conjugated hollow mesoporous silica for controlled drug release.用于控释药物的氧化还原和pH双重响应性聚乙二醇与壳聚糖共轭的中空介孔二氧化硅
Mater Sci Eng C Mater Biol Appl. 2016 Oct 1;67:26-33. doi: 10.1016/j.msec.2016.04.091. Epub 2016 Apr 28.
9
Hierarchical bioresponsive nanocarriers for codelivery of curcumin and doxorubicin.用于姜黄素和阿霉素共递送的分级生物响应性纳米载体。
Colloids Surf B Biointerfaces. 2019 Aug 1;180:93-101. doi: 10.1016/j.colsurfb.2019.04.023. Epub 2019 Apr 21.
10
Thermo-responsive mesoporous silica/lipid bilayer hybrid nanoparticles for doxorubicin on-demand delivery and reduced premature release.温敏介孔硅/脂质双层杂化纳米粒用于阿霉素按需释放和减少早期释放。
Colloids Surf B Biointerfaces. 2017 Dec 1;160:527-534. doi: 10.1016/j.colsurfb.2017.10.005. Epub 2017 Oct 5.

引用本文的文献

1
Functionalized chitosan as nano-delivery platform for CRISPR-Cas9 in cancer treatment.功能化壳聚糖作为CRISPR-Cas9在癌症治疗中的纳米递送平台。
Asian J Pharm Sci. 2025 Jun;20(3):101041. doi: 10.1016/j.ajps.2025.101041. Epub 2025 Feb 26.
2
Evaluation of anticancer efficacy of survivin si-RNA functionalized combined drug-loaded mesoporous silica nanoparticles in a lung cancer mouse model.生存素小干扰RNA功能化载联合药物的介孔二氧化硅纳米粒在肺癌小鼠模型中的抗癌疗效评估
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jun;398(6):7545-7557. doi: 10.1007/s00210-024-03751-y. Epub 2025 Jan 8.
3
Advancements in -Based Anti-Tumor Gene Therapy Research.
基于 的抗肿瘤基因治疗研究进展。
Molecules. 2024 Nov 11;29(22):5315. doi: 10.3390/molecules29225315.
4
Redox-manipulating nanocarriers for anticancer drug delivery: a systematic review.用于抗癌药物递送的氧化还原操纵纳米载体:系统评价。
J Nanobiotechnology. 2024 Sep 28;22(1):587. doi: 10.1186/s12951-024-02859-w.
5
Dansyl fluorophore functionalized hierarchically structured mesoporous silica nanoparticles as novel latent fingerprint development agents.丹磺酰荧光团功能化的分级结构介孔二氧化硅纳米粒子作为新型潜在指纹显影剂。
RSC Adv. 2024 Jul 17;14(31):22504-22512. doi: 10.1039/d4ra03074e. eCollection 2024 Jul 12.
6
Evidence That a Peptide-Drug/p53 Gene Complex Promotes Cognate Gene Expression and Inhibits the Viability of Glioblastoma Cells.肽-药物/p53基因复合物促进同源基因表达并抑制胶质母细胞瘤细胞活力的证据。
Pharmaceutics. 2024 Jun 8;16(6):781. doi: 10.3390/pharmaceutics16060781.
7
Inorganic nanoparticle-cored dendrimers for biomedical applications: A review.用于生物医学应用的无机纳米粒子核树枝状大分子:综述
Heliyon. 2024 Apr 16;10(9):e29726. doi: 10.1016/j.heliyon.2024.e29726. eCollection 2024 May 15.
8
Surface Modification of Mesoporous Silica Nanoparticles for Application in Targeted Delivery Systems of Antitumour Drugs.用于抗肿瘤药物靶向递送系统的介孔二氧化硅纳米颗粒的表面修饰
Polymers (Basel). 2024 Apr 16;16(8):1105. doi: 10.3390/polym16081105.
9
Recent Advances in Micro- and Nano-Drug Delivery Systems Based on Natural and Synthetic Biomaterials.基于天然和合成生物材料的微纳米药物递送系统的最新进展
Polymers (Basel). 2023 Nov 28;15(23):4563. doi: 10.3390/polym15234563.
10
Biomaterial-based gene therapy.基于生物材料的基因治疗。
MedComm (2020). 2023 Jun 3;4(3):e259. doi: 10.1002/mco2.259. eCollection 2023 Jun.